Lineage Cell Therapeutics
LCTX
#8656
Rank
C$0.15 B
Marketcap
$0.84
Share price
-6.45%
Change (1 day)
-36.27%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -C$34.61 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$6.18 Million. In 2023 the company made an earning of -C$34.56 Million a decrease over its 2022 earnings that were of -C$31.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$34.61 Million0.15%
2023 -C$34.56 Million9.83%
2022 -C$31.46 Million-54.24%
2021 -C$68.75 Million86.07%
2020 -C$36.95 Million-31.97%
2019 -C$54.31 Million-5.42%
2018 -C$57.42 Million1.1%
2017 -C$56.8 Million-31.06%
2016 -C$82.38 Million-10.38%
2015 -C$91.93 Million29.69%
2014 -C$70.89 Million31.68%
2013 -C$53.83 Million
2011 -C$26.13 Million89.78%
2010 -C$13.77 Million206.06%
2009 -C$4.5 Million-0.58%
2008 -C$4.53 Million164.89%
2007 -C$1.71 Million-30.22%
2006 -C$2.45 Million
2002 -C$2.85 Million-41.04%
2001 -C$4.83 Million-32.04%
2000 -C$7.1 Million-11.85%
1999 -C$8.05 Million
1997 -C$5.17 Million12.12%
1996 -C$4.62 Million106.25%
1995 -C$2.24 Million-11.11%
1994 -C$2.52 Million50%
1993 -C$1.68 Million20%
1992 -C$1.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.18 Billion 388.83%๐Ÿ‡บ๐Ÿ‡ธ USA